Patent · US Active

Method and systems for prediction of HLA class II-specific epitopes and characterization of CD4+ T cells

US11183272B2 · kind B2 · utility

3Cited by
85References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 19, 2020
Grant dateNov 23, 2021
Priority date—
Expiry dateMar 19, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B25/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for preparing a personalized cancer vaccine and a method to train a machine-learning HLA-peptide presentation prediction model.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.